Business Standard

Sun Pharmaceuticals to see drop in revenue owing to IT security incident

Indian drugmaker Sun Pharmaceutical Industries Ltd would see a revenue drop in a few of its businesses and incur some expenses due to an IT security incident that happened earlier this month

Sun Pharma

Sun Pharma

Reuters BENGALURU

Listen to This Article

Indian drugmaker Sun Pharmaceutical Industries Ltd would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" that happened earlier this month.
The effect of the incident on the drug major's IT systems included a breach of certain file systems and theft of some company and personal data, Sun Pharma said in a filing late on Sunday. A ransomware group has claimed responsibility for the incident, it added.
Sun Pharma, known for its consumer healthcare products such as Revital vitamins and pain relief medicine Volini, posted a near 14% jump in total revenue from operations to 112.41 billion rupees ($1.37 billion) in the last quarter.
The drugmaker on March 2 reported the information security incident, adding that it had not impacted the company's operations. However, on Sunday, the company said its containment measures had affected its operations.
Sun Pharma said it took steps to remediate the impact with the help of experts and "enhanced" security measures to address the situation.
The company said it was unable to determine other potential adverse impacts of the incident, including higher costs and the possibility of litigation.
($1 = 82.3500 Indian rupees)
 
 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 27 2023 | 10:38 AM IST

Explore News